Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

AstraZeneca Aktie: Performance überzeugt erneut

AstraZeneca befindet sich an einem entscheidenden Punkt, während die Pharmamärkte mit sich entwickelnden wirtschaftlichen Belastungen und veränderter Anlegerstimmung konfrontiert sind.…

Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know

In the latest trading session, Astrazeneca (AZN) closed at $75.57, marking a +1.79% move from the previous day.…

UBS stuft ASTRAZENECA auf Buy

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Astrazeneca auf "Buy" mit einem Kursziel von 14200…

Director/PDMR Shareholding

7 March 2025 Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that, on 6 March 2025, an award of…

AstraZeneca’s Imfinzi success a step towards $80bn revenue aim

AstraZeneca PLC has edged closer to its aim of generating $80 billion in revenue come 2030 on positive results from…

Astrazeneca (AZN) Stock Moves -0.63%: What You Should Know

In the closing of the recent trading day, Astrazeneca (AZN) stood at $77.47, denoting a -0.63% change from the preceding…

Better Quantum Computing Stock: Rigetti Computing vs. IonQ

After the rapid rise of the artificial intelligence (AI) industry, the next hot sector could be quantum computing. Quantum technology…

Total Voting Rights

3 March 2025 Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…

Heres Why Astrazeneca (AZN) Gained But Lagged the Market Today

In the closing of the recent trading day, Astrazeneca (AZN) stood at $76.21, denoting a +0.74% change from the preceding…

Astrazeneca überzeugt mit Daten zu Brustkrebsmittel

CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca hat positive Daten zu einem Medikamentenkandidaten zur Behandlung von Brustkrebs vorgelegt. Der Wirkstoff…

dpa-AFX ProFeed